These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31912373)

  • 21. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
    Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
    Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience.
    Daniel F; Hassoun L; Husni M; Sharara A; Soweid A; Barada K; Haffar B; Massoud R; Shaib Y; Al-Hashash J; Bazarbachi A; El Cheikh J
    Curr Res Transl Med; 2019 Feb; 67(1):16-19. PubMed ID: 30206046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute graft-versus-host disease is more prevalent and severe in the lower than the upper gastrointestinal tract.
    Ma C; Maluf HM; Liu TC
    Hum Pathol; 2015 Oct; 46(10):1480-7. PubMed ID: 26243672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Villous atrophy in the terminal ileum is a specific endoscopic finding correlated with histological evidence and poor prognosis in acute graft-versus-host disease after allo-hematopoietic stem cell transplantation.
    Sugihara Y; Hiraoka S; Fujii N; Takashima S; Yamasaki Y; Inokuchi T; Takahara M; Kuwaki K; Harada K; Tanaka T; Okada H
    BMC Gastroenterol; 2018 Jul; 18(1):111. PubMed ID: 29996762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of endoscopic features of pediatric acute gastrointestinal graft-versus-host disease.
    Hiejima E; Nakase H; Matsuura M; Honzawa Y; Higuchi H; Saida S; Umeda K; Hiramatsu H; Adachi S; Izawa K; Kawai T; Yasumi T; Nishikomori R; Heike T
    Dig Endosc; 2016 Jul; 28(5):548-55. PubMed ID: 26773564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid treatment of acute graft-
    Bacigalupo A; Milone G; Cupri A; Severino A; Fagioli F; Berger M; Santarone S; Chiusolo P; Sica S; Mammoliti S; Sorasio R; Massi D; Van Lint MT; Raiola AM; Gualandi F; Selleri C; Sormani MP; Signori A; Risitano A; Bonifazi F;
    Haematologica; 2017 Dec; 102(12):2125-2133. PubMed ID: 28971905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies.
    Ross WA; Ghosh S; Dekovich AA; Liu S; Ayers GD; Cleary KR; Lee JH; Couriel D
    Am J Gastroenterol; 2008 Apr; 103(4):982-9. PubMed ID: 18028511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
    Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
    Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of histologic grade with acute graft-versus-host disease response and outcomes.
    Narkhede M; Rybicki L; Abounader D; Bolwell B; Dean R; Gerds AT; Hanna R; Hill B; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS; Ky Hamilton B
    Am J Hematol; 2017 Jul; 92(7):683-688. PubMed ID: 28376566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic evaluation in gastrointestinal graft-versus-host disease: comparisons with histological findings.
    Cheung DY; Kim JI; Kim SS; Sung HY; Cho SH; Park SH; Han JY; Kim JK; Lee JW; Min WS; Park GS; Kang CS
    Dig Dis Sci; 2008 Nov; 53(11):2947-54. PubMed ID: 18401714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.
    MacMillan ML; Weisdorf DJ; Davies SM; DeFor TE; Burns LJ; Ramsay NK; Wagner JE; Blazar BR
    Biol Blood Marrow Transplant; 2002; 8(1):40-6. PubMed ID: 11858189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD123 is a useful immunohistochemical marker to facilitate diagnosis of acute graft-versus-host disease in colon.
    Lin J; Chen S; Zhao Z; Cummings OW; Fan R
    Hum Pathol; 2013 Oct; 44(10):2075-80. PubMed ID: 23791208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic disagreement between clinical standard histopathological- and retrospective assessment of histopathology-based gastrointestinal graft-versus-host disease in children.
    Mårtensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Mattsson J; Gustafsson B; Casswall TH
    Pediatr Transplant; 2020 Dec; 24(8):e13824. PubMed ID: 33085820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.
    Kameda K; Kako S; Hayakawa J; Akahoshi Y; Komiya Y; Harada N; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Kanda J; Tanihara A; Wada H; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kanda Y
    Ann Hematol; 2018 Jan; 97(1):169-179. PubMed ID: 28965134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
    Holmberg L; Kikuchi K; Gooley TA; Adams KM; Hockenbery DM; Flowers ME; Schoch HG; Bensinger W; McDonald GB
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):226-34. PubMed ID: 16443520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insight for the diagnosis of gastrointestinal acute graft-versus-host disease.
    Malard F; Mohty M
    Mediators Inflamm; 2014; 2014():701013. PubMed ID: 24733964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation.
    Quellmann S; Schwarzer G; Hübel K; Greb A; Engert A; Bohlius J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD004885. PubMed ID: 18646116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.